![Pharmaceuticals policy / Pharmacology / Rare disease / National Organization for Rare Disorders / Pharmaceutical sciences / Pharmaceutical drug / Patient Protection and Affordable Care Act / Law / Orphan Drug Act / Health / Drug discovery / Orphan drug Pharmaceuticals policy / Pharmacology / Rare disease / National Organization for Rare Disorders / Pharmaceutical sciences / Pharmaceutical drug / Patient Protection and Affordable Care Act / Law / Orphan Drug Act / Health / Drug discovery / Orphan drug](https://www.pdfsearch.io/img/0e9d8a49d73a9ed93e6761b3bf583fb5.jpg)
| Document Date: 2013-09-26 15:15:11 Open Document File Size: 235,62 KBShare Result on Facebook
City Washington / DC / / Country United States / / / Facility Rayburn House Office Building / / / IndustryTerm pharmaceutical fee / rare disease therapies / annual pharmaceutical fee / annual pharmaceutical fee provision / therapies for all rare disorders / / MedicalCondition rare diseases / rare disorders / rare disease / / Organization National Organization for Rare Disorders / / / Position Peter L. Saltonstall President and CEO / / ProgrammingLanguage DC / / Technology diagnostic tests / /
SocialTag |